Atlas Trials

Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study

Clinical trial NCT07263451 · RECRUITING

Trial details

NCT number
NCT07263451
Sponsor
Tian'an Jiang
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2025-12-11
Primary completion
2026-03-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.